Lukas Binder

486 total citations
10 papers, 234 citations indexed

About

Lukas Binder is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Lukas Binder has authored 10 papers receiving a total of 234 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 3 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in Lukas Binder's work include Inflammatory Bowel Disease (3 papers), Microscopic Colitis (2 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). Lukas Binder is often cited by papers focused on Inflammatory Bowel Disease (3 papers), Microscopic Colitis (2 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). Lukas Binder collaborates with scholars based in Austria, Switzerland and Canada. Lukas Binder's co-authors include Yongde Bao, Jessica Rodriguez, Arthur Weltman, Sandra G. Burks, James T. Patrie, Patcharin Pramoonjago, Curtis K. Argo, Carolin Lackner, Abdullah Al‐Osaimi and Neeral L. Shah and has published in prestigious journals such as Nature Communications, Gut and Journal of Hepatology.

In The Last Decade

Lukas Binder

9 papers receiving 230 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lukas Binder Austria 5 188 117 63 42 27 10 234
Jacob George Australia 5 246 1.3× 116 1.0× 95 1.5× 46 1.1× 7 0.3× 17 322
Laura G. Draijer Netherlands 7 223 1.2× 122 1.0× 81 1.3× 31 0.7× 8 0.3× 14 265
Elmer Schabel Germany 6 236 1.3× 103 0.9× 120 1.9× 33 0.8× 6 0.2× 8 266
Cristina Muzîca Romania 9 263 1.4× 78 0.7× 174 2.8× 36 0.9× 11 0.4× 48 364
Anna Ozaki Japan 7 251 1.3× 116 1.0× 104 1.7× 37 0.9× 8 0.3× 16 306
Mahmoud Karimi Azardaryany Australia 6 259 1.4× 113 1.0× 102 1.6× 45 1.1× 4 0.1× 6 364
Hilde Løland von Volkmann Norway 7 267 1.4× 190 1.6× 76 1.2× 53 1.3× 5 0.2× 13 366
Anita Arslanow Germany 6 248 1.3× 80 0.7× 165 2.6× 36 0.9× 3 0.1× 16 279
Bihui Zhong China 10 257 1.4× 79 0.7× 76 1.2× 94 2.2× 9 0.3× 27 314
Koichiro Kusumoto Japan 4 236 1.3× 72 0.6× 137 2.2× 14 0.3× 4 0.1× 6 275

Countries citing papers authored by Lukas Binder

Since Specialization
Citations

This map shows the geographic impact of Lukas Binder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukas Binder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukas Binder more than expected).

Fields of papers citing papers by Lukas Binder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lukas Binder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukas Binder. The network helps show where Lukas Binder may publish in the future.

Co-authorship network of co-authors of Lukas Binder

This figure shows the co-authorship network connecting the top 25 collaborators of Lukas Binder. A scholar is included among the top collaborators of Lukas Binder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lukas Binder. Lukas Binder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Kohl, Paul, Carmen Tam‐Amersdorfer, Kristina Schild-Prüfert, et al.. (2025). Enrichment of human IgA-coated bacterial vesicles in ulcerative colitis as a driver of inflammation. Nature Communications. 16(1). 3995–3995. 6 indexed citations
2.
Blesl, Andreas, Lukas Binder, Bettina Halwachs, et al.. (2025). The Fecal Microbiome of IBD Patients Is Less Divertible by Bowel Preparation Compared to Healthy Controls: Results From a Prospective Study. Inflammatory Bowel Diseases. 31(7). 2007–2018. 1 indexed citations
3.
Chromy, David, et al.. (2024). Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium at pharyngeal and anorectal sites in patients presenting to an STI outpatient ward. Journal of the European Academy of Dermatology and Venereology. 39(2). 389–397.
4.
Blesl, Andreas, Wolfgang Petritsch, Lukas Binder, et al.. (2022). Treatment persistence of ustekinumab and vedolizumab in IBD patients is independent of prior immunogenicity to anti-TNFs: a retrospective study. Scandinavian Journal of Gastroenterology. 57(11). 1327–1330. 1 indexed citations
5.
Reider, Simon, et al.. (2022). Hematopoietic Stem Cell Transplantation in Refractory Crohn’s Disease: Should It Be Considered?. Cells. 11(21). 3463–3463. 7 indexed citations
6.
Blesl, Andreas, Lukas Binder, Christoph Högenauer, et al.. (2021). Limited long‐term treatment persistence of first anti‐TNF therapy in 538 patients with inflammatory bowel diseases: a 20‐year real‐world study. Alimentary Pharmacology & Therapeutics. 54(5). 667–677. 20 indexed citations
7.
Binder, Lukas, Christoph Högenauer, & Cord Langner. (2020). Gastrointestinal effects of an attempt to avoid contracting COVID‐19 by ‘disinfection’. Histopathology. 77(2). 327–328. 10 indexed citations
8.
Rainer, Florian, et al.. (2018). Case of nasogastric tube dysfunction. Gut. 68(2). 206–262. 3 indexed citations
9.
Argo, Curtis K., James T. Patrie, Carolin Lackner, et al.. (2014). Effects of n-3 fish oil on metabolic and histological parameters in NASH: A double-blind, randomized, placebo-controlled trial. Journal of Hepatology. 62(1). 190–197. 185 indexed citations
10.
Griesinger, Frank, Lukas Binder, Pascal F. W. Hannemann, et al.. (1997). Phase II study of taxotere/carboplatin with pharmacokinetics and -Dynamics In NSCLC for downstaging in stage III B and palliation in stage IV. European Journal of Cancer. 33. S232–S232. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacob George Breakdown of academic impact, for papers by Laura G. Draijer Breakdown of academic impact, for papers by Elmer Schabel Breakdown of academic impact, for papers by Cristina Muzîca Breakdown of academic impact, for papers by Anna Ozaki Breakdown of academic impact, for papers by Mahmoud Karimi Azardaryany Breakdown of academic impact, for papers by Hilde Løland von Volkmann Breakdown of academic impact, for papers by Anita Arslanow Breakdown of academic impact, for papers by Bihui Zhong Breakdown of academic impact, for papers by Koichiro Kusumoto
Rankless by CCL
2026